<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the second leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related mortality in Western countries </plain></SENT>
<SENT sid="1" pm="."><plain>Although the aberrant expression of several microRNAs (oncomiRs) is associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression, the molecular mechanisms of this phenomenon are still under investigation </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that miR-101 expression is differentially impaired in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens, depending on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade </plain></SENT>
<SENT sid="3" pm="."><plain>miR-101 re-expression suppresses cell growth in 3D, hypoxic survival and invasive potential in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells showing low levels of miR-101 </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, we provide molecular evidence of a bidirectional regulatory mechanism between miR-101 expression and important <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> pro-malignant features, such as <z:mp ids='MP_0001845'>inflammation</z:mp>, activation of the Wnt/Î²-catenin signalling pathway and epithelial-mesenchymal transition (EMT) </plain></SENT>
<SENT sid="5" pm="."><plain>We then propose that up-regulated miR-101 may function as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and that its pharmacological restoration might hamper the <z:hpo ids='HP_0000718'>aggressive behaviour</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in vivo </plain></SENT>
<SENT sid="6" pm="."><plain>MiR-101 expression may also represent a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> biomarker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnosis and prognosis </plain></SENT>
</text></document>